Artículos de revistas
Adverse Effect Of The Anabolic-androgenic Steroid Mesterolone On Cardiac Remodelling And Lipoprotein Profile Is Attenuated By Aerobicz Exercise Training
Registro en:
International Journal Of Experimental Pathology. , v. 89, n. 5, p. 358 - 366, 2008.
9599673
10.1111/j.1365-2613.2008.00601.x
2-s2.0-51349094273
Autor
Fontana K.
Oliveira H.C.F.
Leonardo M.B.
Mandarim-De-Lacerda C.A.
Da Cruz-Hofling M.A.
Institución
Resumen
Abuse of anabolic-androgenic steroids (AAS) for improving physical performance is associated with serious, sometimes fatal, adverse effects. The aim of the present work was to investigate the effects of AAS on the cardiac structure and the plasma lipoprotein profile isolated and in combination with exercise. Transgenic mice with a human lipaemic phenotype (expressing cholesteryl ester transfer protein on the LDL receptor knockout background) were used in this study. Sedentary and exercised mice (treadmill running, five times per week for 6 weeks) were treated with mesterolone (2 μg/g body weight) or vehicle (control-C) in the last 3 weeks. Four groups were compared: (i) exercise + mesterolone (Ex-M), (ii) exercise + vehicle (Ex-C), (iii) sedentary + mesterolone (Sed-M) and (iv) sedentary + vehicle (Sed-C). Arterial blood pressure and body mass increased in all groups along time, but Sed-M reached the highest values and Ex-C the lowest. Treatment with mesterolone increased total cholesterol, triglyceride, low-density lipoprotein cholesterol (LDL-c) and very LDL-c (VLDL-c) plasma levels. However, exercise blunted some of these deleterious effects by increasing high-density lipoprotein cholesterol and decreasing LDL-c, VLDL-c and triglycerides. Exercise training induced beneficial effects, such as physiological cardiomyocyte hypertrophy, increase in myocardial circulation and decrease in cardiac interstitium. However, mesterolone impaired such physiological gains and in addition increased troponin T plasma levels both in sedentary and exercised mice. Thus, while mesterolone induced pro-atherogenic lipoprotein profile and pathogenic cardiac hypertrophy, exercise counteracted these effects and modified favourably both the lipoprotein profile and the cardiac remodelling induced by mesterolone. © 2008 The Authors. 89 5 358 366 Alen, M., Rahkila, P., Reduced high-density lipoprotein-cholesterol in power athletes: Use of male sex hormone derivates, an atherogenic factor (1984) Int. J. Sports Med., 5, pp. 341-342 Basaria, S., Wahlstrom, J.T., Dobs, A.S., Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases (2001) J. Clin. Endocrinol. Metab., 86, pp. 5108-5117 Bauman, D.H., Richerson, J.T., Britt, A.L., A comparison of body and organ weights, physiologic parameters, and pathologic changes in target organs of rats given combinations of exercise, anabolic hormone, and protein supplementation (1988) Am. J. Sports Med., 16, pp. 397-402 Blair, S.N., Lamonte, M.J., Nichaman, M.Z., The evolution of physical activity recommendations: How much is enough? (2004) Am. J. Clin. Nutr., 79, pp. 913S-920S Casquero, A.C., Berti, J.A., Salerno, A.G., Atherosclerosis is enhanced by testosterone deficiency and attenuated by CETP expression in transgenic mice (2006) J. Lipid Res., 47, pp. 1526-1534 Cazita, P.M., Berti, J.A., Aoki, C., Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice (2003) J. Lipid Res., 44, pp. 33-40 Codipilly, C.N., Teichberg, S., Wapnir, R.A., Enhancement of absorption by gum arabic in a model of gastrointestinal dysfunction (2006) J. Am. Coll. Nutr., 25, pp. 307-312 Dickerman, R.D., McConathy, W.J., Schaller, F., Cardiovascular complications and anabolic steroids (1996) Eur. Heart J., 17, p. 1912 Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge (1972) Clin. Chem., 18, pp. 499-502 Ganten, U., Schroder, G., Witt, M., Sexual dimorphism of blood pressure in spontaneously hypertensive rats: Effects of anti-androgen treatment (1989) J. Hypertens., 7, pp. 721-726 Glazer, G., Atherogenic effects of anabolic steroids on serum lipid levels. a literature review (1991) Arch. Intern. Med., 151, pp. 1925-1933 Gundersen, H.J., Notes on the estimation of the numerical density of arbitrary profiles: The edge effect (1977) J. Microsc., 111, pp. 219-227 Halverstadt, A., Phares, D.A., Wilund, K.R., Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women (2007) Metabolism, 56, pp. 444-450 Hartgens, F., Kuipers, H., Effects of androgenic-anabolic steroids in athletes (2004) Sports Med., 34, pp. 513-554 Hurley, B.F., Seals, D.R., Hagberg, J.M., High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use (1984) J. Am. Med. Assoc., 252, pp. 507-513 Kraus, W.E., Houmard, J.A., Duscha, B.D., Effects of the amount and intensity of exercise on plasma lipoproteins (2002) N. Engl. J. Med., 347, pp. 1483-1492 Larosa, J.C., Lipids and cardiovascular disease: Do the findings and therapy apply equally to men and women? (1992) Womens Health Issues, 2, pp. 102-111 Mandarim-De-Lacerda, C.A., Stereological tools in biomedical research (2003) Ann. Braz. Acad. Sci., 75, pp. 469-486 Marques, C.M., Nascimento, F.A., Mandarim-De-Lacerda, C.A., Exercise training attenuates cardiovascular adverse remodeling in adult ovariectomized spontaneously hypertensive rats (2006) Menopause, 13, pp. 87-95 Nieminen, M.S., Ramo, M.P., Viitasalo, M., Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters (1996) Eur. Heart J., 17, pp. 1576-1583 Rockhold, R.W., Cardiovascular toxicity of anabolic steroids (1993) Annu. Rev. Pharmacol. Toxicol., 33, pp. 497-520 Seals, D.R., Hagberg, J.M., Hurley, B.F., Effects of endurance training on glucose tolerance and plasma lipid levels in older men and women (1984) JAMA, 252, pp. 645-649 Smolka, M.B., Zoppi, C.C., Alves, A.A., HSP72 as a complementary protection against oxidative stress induced by exercise in the soleus muscle of rats (2000) Am. J. Physiol. Regul. Integr. Comp. Physiol., 279, pp. R1539-R1545 Sullivan, M.L., Martinez, C.M., Gennis, P., The cardiac toxicity of anabolic steroids (1998) Prog. Cardiovasc. Dis., 41, pp. 1-15 Tagarakis, C.V., Bloch, W., Hartmann, G., Anabolic steroids impair the exercise-induced growth of the cardiac capillary bed (2000) Int. J. Sports Med., 21, pp. 412-418 Tagarakis, C.V., Bloch, W., Hartmann, G., Testosterone-propionate impairs the response of the cardiac capillary bed to exercise (2000) Med. Sci. Sports Exerc., 32, pp. 946-953 Urhausen, A., Albers, T., Kindermann, W., Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? (2004) Heart, 90, pp. 496-501 Vermeulen, A., Androgen replacement therapy in the aging male - A critical evaluation (2001) J. Clin. Endocrinol. Metab., 86, pp. 2380-2390 Wang, M., Tsai, B.M., Kher, A., Role of endogenous testosterone in myocardial proinflammatory and proapoptotic signaling after acute ischemia-reperfusion (2005) Am. J. Physiol. Heart Circ. Physiol., 288, pp. H221-H226 Winkler, U.H., Effects of androgens on haemostasis (1996) Maturitas, 24, pp. 147-155 Woodiwiss, A.J., Trifunovic, B., Philippides, M., Effects of an androgenic steroid on exercise-induced cardiac remodeling in rats (2000) J. Appl. Physiol., 88, pp. 409-415